Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:40889285

MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous samples.

Tianci Wang · Xin Lai · Shenjie Wang · Yuqian Liu · Xiaoyan Zhu · Jiayin Wang

Bioinformatics (Oxford, England) · 2025 doi:10.1093/bioinformatics/btaf485

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:40889285
kind
science-record
content_hash
sha256:080b8371ffecd0d1324881b5b823849cb3253d5be2ad219dd72fb9412db7e305
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T20:31:00Z
updated_at
2026-11-01T21:35:43Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous samples.
doi
10.1093/bioinformatics/btaf485
pmid
40889285
authors array · 6 items
[0]
Tianci Wang
[1]
Xin Lai
[2]
Shenjie Wang
[3]
Yuqian Liu
[4]
Xiaoyan Zhu
[5]
Jiayin Wang
journal
Bioinformatics (Oxford, England)
year
2025
abstract
MOTIVATION: Minimal residual disease (MRD) as critical biomarker for cancer prognosis and management plays a crucial role in improving patient outcomes. However, detecting MRD via next-generation sequencing-based circulating tumor DNA variant calling remains unstable due to the extremely low variant allele frequency and significant inter- and intra-sample heterogeneity. Although parameter optimization can theoretically enhance the detection performance of variants, achieving stable MRD detection remains challenging due to three key factors: (i) the necessity for individualized parameter tuning across numerous heterogeneous genomic intervals within each sample, (ii) the tightly interdependent parameter requirements across different stages of variant detection workflows, and (iii) the limitations of current automated parameter optimization methods. RESULTS: In this study, we propose MRDagent, a novel variant detection tool designed specifically for MRD detection. MRDagent incorporates an iterative and self-adaptive optimization framework capable of handling unknown objectives, varying constraints, and highly coupled parameters across stages. A key innovation of MRDagent is the integration of a convolutional neural network-based meta-model, trained on historical data to enable rapid parameter prediction. This significantly enhances computational efficiency and generalization performance. Extensive evaluations on simulated and real-world datasets demonstrate MRDagent's superior and stable performance, providing an efficient, reliable solution for MRD detection in clinical and high-throughput research applications. AVAILABILITY AND IMPLEMENTATION: MRDagent is freely available at https://github.com/aAT0047/MRDagent.git. The corresponding dataset and software archive are available at Zenodo: https://doi.org/10.5281/zenodo.15458496.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Finally, we used a 10-fold cross-validation approach to rigorously evaluate the CNN-based meta-model, enabling rapid generalization from previous tasks across samples and genomic regions to new tasks.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:40889285
locator
sections[11] "2.4.3 Training process" paragraph 2
quote
Finally, we used a 10-fold cross-validation approach to rigorously evaluate the CNN-based meta-model, enabling rapid generalization from previous tasks across samples and genomic regions to new tasks.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The data underlying this article were accessed from the International Cancer Genome Consortium (ICGC, https://dcc.icgc.org/). Access to the original data requires compliance with the ICGC Data Access Policies and approval by the relevant Data Access Committee. The derived data generated in this study are available from the corresponding author upon reasonable request.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:40889285
locator
sections[30] "Data availability" paragraph 2
quote
The data underlying this article were accessed from the International Cancer Genome Consortium (ICGC, https://dcc.icgc.org/). Access to the original data requires compliance with the ICGC Data Access Policies and approval by the relevant Data Access Committee. The derived data generated in this study are available from the corresponding author upon reasonable request.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
MRDagent attained a mean F1 score of 0.78 across the 473 subsamples, with a variance of merely 0.04, and notably lower RMSE and CV compared to other methods.
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:40889285
locator
sections[17] "3.2.3 Stability analysis of intrasample samples" paragraph 2
quote
MRDagent attained a mean F1 score of 0.78 across the 473 subsamples, with a variance of merely 0.04, and notably lower RMSE and CV compared to other methods.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
MRDagent attained a mean F1 score of 0.78 across the 473 subsamples, with a variance of merely 0.04, and notably lower RMSE and CV compared to other methods.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:40889285
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 1 item
[0] object · 15 fields
id
source:pmid:40889285
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1093/bioinformatics/btaf485
sha256
sha256:4e2ac6d6453b19a8860ddf0547012cb8d406b634f3731778234e559137203aeb
bytes
44845
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1093/bioinformatics/btaf485
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC12462387
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
gaps array · 0 items
analysis object · 4 fields
state
partial
methods array · 1 item
[0] object · 10 fields
id
method-1
family
null
specific
null
label
10-fold cross-validation
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
Finally, we used a 10-fold cross-validation approach to rigorously evaluate the CNN-based meta-model, enabling rapid generalization from previous tasks across samples and genomic regions to new tasks.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (10-fold cross-validation), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 0 items
resolved_accessions array · 0 items
statements array · 1 item
[0]
The data underlying this article were accessed from the International Cancer Genome Consortium (ICGC, https://dcc.icgc.org/). Access to the original data requires compliance with the ICGC Data Access Policies and approval by the relevant Data Access Committee. The derived data generated in this study are available from the corresponding author upon reasonable request.
basis
The paper names no accession to its source data, so the data has to come from the authors.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 1 item
[0]
source:pmid:40889285
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T20:00:53Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
12032
completion_tokens
1668
cached_tokens
128
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:40889285
type
paper
label
pmid:40889285
[1] object · 3 fields
id
source:pmid:40889285
type
manuscript
label
PMID 40889285 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:40889285
type
paper
label
pmid:40889285
[1] object · 3 fields
id
source:pmid:40889285
type
manuscript
label
PMID 40889285 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-40889285
type
extraction
used array · 1 item
[0]
source:pmid:40889285
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:40889285
parent_hash
sha256:f8d13e47a1a7b4bef8e2fca3215f88b3f5b39989b93d4856cb1a6634086d7ae1
fork_of
null
gaps array · 6 items
[0]
execution.not_run
[1]
method.reader_named_unmapped
[2]
review.human_critique
[3]
review.independent_reader
[4]
review.machine_critique
[5]
step:obtain_source_data blocked on data:accession_absent
assays array · 1 item
[0] object · 11 fields
role
data_generation
definition_id
amplicon_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
patient outcomes. However, detecting MRD via next-generation sequencing-based circulating tumor DNA variant calling
[1]
on typically uses ctDNA as input, leveraging NGS to obtain high-resolution genomic data, foll
[2]
workflow of ctDNA-based MRD detection using NGS. ctDNA is extracted from plasma samples and
[3]
tracted from plasma samples and subjected to NGS to obtain high-resolution genomic data. Vari
order_basis
paper_text_order:254
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:40889285", "kind": "science-record", "revision": 2, "content_hash": "sha256:080b8371ffecd0d1324881b5b823849cb3253d5be2ad219dd72fb9412db7e305", "created_at": "2026-11-01T20:31:00Z", "updated_at": "2026-11-01T21:35:43Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous samples.", "doi": "10.1093/bioinformatics/btaf485", "pmid": "40889285", "authors": ["Tianci Wang", "Xin Lai", "Shenjie Wang", "Yuqian Liu", "Xiaoyan Zhu", "Jiayin Wang"], "journal": "Bioinformatics (Oxford, England)", "year": 2025, "abstract": "MOTIVATION: Minimal residual disease (MRD) as critical biomarker for cancer prognosis and management plays a crucial role in improving patient outcomes. However, detecting MRD via next-generation sequencing-based circulating tumor DNA variant calling remains unstable due to the extremely low variant allele frequency and significant inter- and intra-sample heterogeneity. Although parameter optimization can theoretically enhance the detection performance of variants, achieving stable MRD detection remains challenging due to three key factors: (i) the necessity for individualized parameter tuning across numerous heterogeneous genomic intervals within each sample, (ii) the tightly interdependent parameter requirements across different stages of variant detection workflows, and (iii) the limitations of current automated parameter optimization methods.\nRESULTS: In this study, we propose MRDagent, a novel variant detection tool designed specifically for MRD detection. MRDagent incorporates an iterative and self-adaptive optimization framework capable of handling unknown objectives, varying constraints, and highly coupled parameters across stages. A key innovation of MRDagent is the integration of a convolutional neural network-based meta-model, trained on historical data to enable rapid parameter prediction. This significantly enhances computational efficiency and generalization performance. Extensive evaluations on simulated and real-world datasets demonstrate MRDagent's superior and stable performance, providing an efficient, reliable solution for MRD detection in clinical and high-throughput research applications.\nAVAILABILITY AND IMPLEMENTATION: MRDagent is freely available at https://github.com/aAT0047/MRDagent.git. The corresponding dataset and software archive are available at Zenodo: https://doi.org/10.5281/zenodo.15458496.", "claims": [{"id": "claim-method", "statement": "Finally, we used a 10-fold cross-validation approach to rigorously evaluate the CNN-based meta-model, enabling rapid generalization from previous tasks across samples and genomic regions to new tasks.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:40889285", "locator": "sections[11] \"2.4.3 Training process\" paragraph 2", "quote": "Finally, we used a 10-fold cross-validation approach to rigorously evaluate the CNN-based meta-model, enabling rapid generalization from previous tasks across samples and genomic regions to new tasks."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The data underlying this article were accessed from the International Cancer Genome Consortium (ICGC, https://dcc.icgc.org/). Access to the original data requires compliance with the ICGC Data Access Policies and approval by the relevant Data Access Committee. The derived data generated in this study are available from the corresponding author upon reasonable request.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:40889285", "locator": "sections[30] \"Data availability\" paragraph 2", "quote": "The data underlying this article were accessed from the International Cancer Genome Consortium (ICGC, https://dcc.icgc.org/). Access to the original data requires compliance with the ICGC Data Access Policies and approval by the relevant Data Access Committee. The derived data generated in this study are available from the corresponding author upon reasonable request."}], "state": "complete"}, {"id": "claim-target-result", "statement": "MRDagent attained a mean F1 score of 0.78 across the 473 subsamples, with a variance of merely 0.04, and notably lower RMSE and CV compared to other methods.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:40889285", "locator": "sections[17] \"3.2.3 Stability analysis of intrasample samples\" paragraph 2", "quote": "MRDagent attained a mean F1 score of 0.78 across the 473 subsamples, with a variance of merely 0.04, and notably lower RMSE and CV compared to other methods."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "MRDagent attained a mean F1 score of 0.78 across the 473 subsamples, with a variance of merely 0.04, and notably lower RMSE and CV compared to other methods.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:40889285"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:40889285", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1093/bioinformatics/btaf485", "sha256": "sha256:4e2ac6d6453b19a8860ddf0547012cb8d406b634f3731778234e559137203aeb", "bytes": 44845, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1093/bioinformatics/btaf485", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC12462387", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "10-fold cross-validation", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Finally, we used a 10-fold cross-validation approach to rigorously evaluate the CNN-based meta-model, enabling rapid generalization from previous tasks across samples and genomic regions to new tasks."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (10-fold cross-validation), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["The data underlying this article were accessed from the International Cancer Genome Consortium (ICGC, https://dcc.icgc.org/). Access to the original data requires compliance with the ICGC Data Access Policies and approval by the relevant Data Access Committee. The derived data generated in this study are available from the corresponding author upon reasonable request."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:40889285"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T20:00:53Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 12032, "completion_tokens": 1668, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:40889285", "type": "paper", "label": "pmid:40889285"}, {"id": "source:pmid:40889285", "type": "manuscript", "label": "PMID 40889285 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:40889285", "type": "paper", "label": "pmid:40889285"}, {"id": "source:pmid:40889285", "type": "manuscript", "label": "PMID 40889285 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-40889285", "type": "extraction", "used": ["source:pmid:40889285"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:40889285", "parent_hash": "sha256:f8d13e47a1a7b4bef8e2fca3215f88b3f5b39989b93d4856cb1a6634086d7ae1", "fork_of": null, "generation": 1}, "gaps": ["execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "data_generation", "definition_id": "amplicon_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["patient outcomes. However, detecting MRD via next-generation sequencing-based circulating tumor DNA variant calling", "on typically uses ctDNA as input, leveraging NGS to obtain high-resolution genomic data, foll", "workflow of ctDNA-based MRD detection using NGS. ctDNA is extracted from plasma samples and", "tracted from plasma samples and subjected to NGS to obtain high-resolution genomic data. Vari"], "order_basis": "paper_text_order:254", "id": "assay:1"}]}